NASDAQ

CAI

Caris Life Sciences, Inc.

☾After Hours −4.36 (−13.10%)Nov 4, 7:59 PM ET

At close $33.23 · +0.38 (+1.17%)

Mkt Cap
$9.4B
Volume
2.9M
52W High
$36.50
52W Low
$14.19
PE Ratio
89.3
Avg Vol
3.7M
As of 11/3/26
Div Yield
—
Beta
1.51
As of 11/3/26

Company

Headquarters
Irving, TX
Employees
1,846 (2026)
Listed
Jun 18, 2025
Exchange
Nasdaq
SEC industry
Services-Medical Laboratories

Diagnostics

  • Market cap #6 of 39
  • P/B #5 of 37

Ranked highest first among stocks Cylvex covers.

  1. NTRANatera, Inc.$56.37B+0.63%
  2. IDXXIdexx Laboratories Inc$55.09B+4.06%
  3. LHLabcorp Holdings Inc.$29.86B+3.92%
  4. DGXQuest Diagnostics Inc.$28.21B+3.46%
  5. GHGuardant Health, Inc.$22.65B-3.54%
All Diagnostics ›

Financial summary

Related companies

About

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

From company filings and market data · Not investment advice

Price data

Day Low $31.91Day High $34.84
52W Low $14.1952W High $36.50
Open
$33.51
Prev Close
$32.85
Volume
2.9M
Avg Vol (30D)
3.6M

From daily bars

Financials

Consensus estimates

The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.